Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 479 (RNA5SP479)

Target
RNA5SP479
Molecular classification
Processed pseudogene, rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 479 (RNA5SP479) is a processed pseudogene observed in the human genome with sequence similarity to functional 5S ribosomal RNA genes[2][1][4][8]. Unlike the canonical 5S rRNA, which is an essential structural RNA component of the large subunit of the ribosome, this pseudogene does not encode a functional product and is not transcribed as ribosomal RNA for ribosome assembly[3][5][7][9]. Evidence for biological involvement is lacking; RNA5SP479 is considered an evolutionary remnant and is not a valid therapeutic target. Its presence is mainly relevant for genomic annotation and evolutionary studies, not for clinical, pharmacological, or diagnostic applications[1][2][6][8]. **Note:** - This gene is annotated as a pseudogene, indicating it is non-functional, lacks biological or therapeutic relevance, and should *not* be considered a therapeutic target[1][2][4][8]. - The entry is "incorrect" as a drug target or therapeutic receptor; its inclusion as a target would be due to misunderstanding of its biology[1][2][8]. - There is no evidence for drugs, safety concerns, clinical impact, or biomarker use. If you require information about the functional 5S ribosomal RNA or ribosomal targets as drug targets (e.g., antibiotics targeting ribosomal RNA in bacteria), request information for "5S ribosomal RNA" rather than for pseudogenes like RNA5SP479[3][5][7][9].

Other names
RN5S479RNA, 5S ribosomal 479RNA5SP479
02

Mechanism of action

Not applicable; no known interacting drugs or therapeutic mechanisms

03

Biological functions

Generally none; pseudogenes are typically non-functional remnants of genomic evolutionMay participate in regulatory functions through RNA-binding protein competition or RNA interference, but no evidence for functional activity in RNA5SP479 specifically
04

Disease associations

No established direct disease associationsPseudogenes as a class can sometimes regulate gene networks and have been occasionally implicated in cancer or other diseases, but this is not documented for RNA5SP479
05

Safety considerations

None known; pseudogenes do not present therapeutic challenges
06

Interacting drugs

None known
07

Biomarkers

None known; not used as a biomarker

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 479 (RNA5SP479).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 479 (RNA5SP479).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call